Eversept Partners, LP Lannett CO Inc Transaction History
Eversept Partners, LP
- $1.26 Billion
- Q3 2024
A detailed history of Eversept Partners, LP transactions in Lannett CO Inc stock. As of the latest transaction made, Eversept Partners, LP holds 63,900 shares of LCI stock, worth $1,917. This represents 62.99% of its overall portfolio holdings.
Number of Shares
63,900Holding current value
$1,917% of portfolio
62.99%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LCI
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About LANNETT CO INC
- Ticker LCI
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 42,960,000
- Market Cap $1.29M
- Description
- Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...